Marathon Petroleum achieved a striking Q1 earnings per share of $1.65, surpassing analysts' expectations by 129% against a consensus estimate of $0.72, with revenues reaching $34.57 billion and exceeding projections by 13.88%. This impressive financial report stands in stark contrast to the deteriorating economic backdrop, as the U.S. Trade Balance revealed a deficit of $60.3 billion in March, worsened from February's $57.8 billion, fueled by import growth of 2.3% and modest export growth of 2%.
“Marathon Petroleum · posted earnings of · +1.65 per share · null”
“Marathon Petroleum · earnings were · +129% higher than · $0.72 in the Zacks consensus”
“Marathon Petroleum · reported revenues of · $34.57 billion · null”
“Marathon Petroleum · revenues were higher than projections by · +13.88% · null”
“U.S. Trade Balance · deficit · March · -$60.3 billion”
“U.S. Trade Balance · previous month's deficit · February · -$57.8 billion”
“U.S. Trade Balance · import growth · March · +2.3%”
“U.S. Trade Balance · export growth · March · +2.0%”
“Pfizer PFE · earnings per share · Q1 · +0.75”
“Pfizer PFE · earnings expectations beat · Q1 · +4 cents”
“Pfizer PFE · revenue · Q1 · $14.45 billion”
“Pfizer PFE · revenue growth · Q1 · +4.56%”
.svg&width=160)
